PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Texas Instruments Incorporated (TXN)
205.980.01 (0.00%)
205.24 - 207.41
139.95 - 221.69
4.54M / 6.54M (Avg.)
37.59 | 5.48
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-7.10%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-6.45%
Negative gross profit growth while MRVL is at 7.50%. Joel Greenblatt would examine cost competitiveness or demand decline.
8.36%
EBIT growth below 50% of MRVL's 103.62%. Michael Burry would suspect deeper competitive or cost structure issues.
-5.45%
Negative operating income growth while MRVL is at 103.62%. Joel Greenblatt would press for urgent turnaround measures.
8.16%
Net income growth under 50% of MRVL's 106.80%. Michael Burry would suspect the firm is falling well behind a key competitor.
4.00%
EPS growth under 50% of MRVL's 108.33%. Michael Burry would suspect deeper structural issues or share dilution limiting per-share gains.
4.08%
Diluted EPS growth under 50% of MRVL's 108.33%. Michael Burry would worry about an eroding competitive position or excessive dilution.
-0.51%
Share reduction while MRVL is at 0.30%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
0.10%
Diluted share reduction more than 1.5x MRVL's 0.74%. David Dodd would validate if the company is aggressively retiring shares or limiting option exercises.
31.30%
Dividend growth above 1.5x MRVL's 0.28%. David Dodd would verify if the firm's cash flow is robust enough for these payouts.
-1.84%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
0.24%
Positive FCF growth while MRVL is negative. John Neff would see a strong competitive edge in net cash generation.
45.31%
10Y revenue/share CAGR 1.25-1.5x MRVL's 40.81%. Bruce Berkowitz would investigate brand strength or geographical expansion fueling growth.
13.86%
Positive 5Y CAGR while MRVL is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
22.94%
Positive 3Y CAGR while MRVL is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
141.93%
Positive long-term OCF/share growth while MRVL is negative. John Neff would see a structural advantage in sustained cash generation.
62.92%
Positive OCF/share growth while MRVL is negative. John Neff might see a comparative advantage in operational cash viability.
26.13%
Positive 3Y OCF/share CAGR while MRVL is negative. John Neff might see a big short-term edge in operational efficiency.
131.02%
Positive 10Y CAGR while MRVL is negative. John Neff might see a substantial advantage in bottom-line trajectory.
300.73%
Positive 5Y CAGR while MRVL is negative. John Neff might view this as a strong mid-term relative advantage.
123.41%
Positive short-term CAGR while MRVL is negative. John Neff would see a clear advantage in near-term profit trajectory.
35.88%
10Y equity/share CAGR at 50-75% of MRVL's 51.89%. Martin Whitman would note a lag in capital accumulation vs. the competitor.
9.07%
Positive 5Y equity/share CAGR while MRVL is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
5.67%
Positive short-term equity growth while MRVL is negative. John Neff sees a strong advantage in near-term net worth buildup.
1168.08%
Dividend/share CAGR of 1168.08% while MRVL is zero. Bruce Berkowitz sees a slight advantage in stepping up payouts steadily.
194.90%
Dividend/share CAGR of 194.90% while MRVL is zero. Bruce Berkowitz sees a minor advantage in stepping up distributions, even modestly.
66.90%
Our short-term dividend growth is positive while MRVL cut theirs. John Neff views it as a comparative advantage in shareholder returns.
-12.44%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
-1.00%
Both reduce inventory yoy. Martin Whitman suspects a broader move to lean operations or industry slowdown in demand.
1.33%
Positive asset growth while MRVL is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
2.34%
Positive BV/share change while MRVL is negative. John Neff sees a clear edge over a competitor losing equity.
-0.06%
We’re deleveraging while MRVL stands at 0.00%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
-2.83%
Both reduce R&D yoy. Martin Whitman sees an industry shifting to cost reduction or limited breakthroughs in the near term.
-7.01%
We cut SG&A while MRVL invests at 2.83%. Joel Greenblatt sees a short-term margin benefit but wonders if the competitor invests for future gains.